Shandong Buchang Pharmaceuticals' (SHA:603858) subsidiary, Shanghai Hepu Medical Technology, agreed to established a joint venture with Sichuan Lindong Enterprise Management Center (Limited Partnership), according to Shanghai bourse filing on Wednesday.
The joint venture company, Sichuan Hepu Tongchuang Medical Technology, will have a registered capital of 4.5 million yuan
Hepu Medical Tech will own 70% of the venture after investing 3.2 million yuan, while Sichuan Lindong will own the remaining 30% after investing 1.4 million yuan.